Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing. - Wikidata - wikimedia - TriplyDB

Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing.

Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing.

http://www.wikidata.org/entity/Q36141301

about

Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes Mouse models of liver cancer: Progress and recommendations Ah Receptor Pathway Intricacies; Signaling Through Diverse Protein Partners and DNA-Motifs A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination The impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection.Increased H3K9me3 drives dedifferentiated phenotype via KLF6 repression in liposarcoma.KLF6-SV1 drives breast cancer metastasis and is associated with poor survival Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis.Exploration of liver cancer genomes.Krüppel-like factors in hepatocellular carcinoma.Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.SP and KLF Transcription Factors in Digestive Physiology and Diseases.Krüppel-like factor 6 is a transcriptional activator of autophagy in acute liver injury.A splicing twist on metastasis.Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools.Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells.Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma

P2860

Q26772317-C292F8B7-2998-4E02-97AF-81E88CE09E04 Q26799788-38B2A960-C75F-40D8-8DEC-30BCCD4C554B Q28384227-EB263363-A80F-4C4A-B4C5-0B0F5B382164 Q28597820-BBF0BCF0-D37C-47DA-8B85-EFF282B3E834 Q33882748-6FFEFDAC-5788-43D1-ACAB-D45464C16CFF Q36040449-2BFE97CA-8565-4921-9F05-540E6B5D5CC0 Q36324431-3B66B0CD-5960-4F3F-8492-2AD1FDF7DCDA Q36781204-CCC8E0D3-F982-415D-BDCB-B81F9A373205 Q38182833-FA5BFF18-82CD-434C-8480-E89C98391426 Q38344470-498CA552-7A39-4F68-8CE6-3DA8EB5E85FA Q38752619-F4A53FFD-01A8-453D-8F69-284EB5C8A88C Q39214035-D1793A21-DE13-432C-B757-18048E25B8CC Q40093274-674EC0C4-E442-40E7-B823-752BDE2EB4E1 Q43731933-9C4ACADE-E53A-4BBF-A323-4602B839EC98 Q47110708-FF681B73-122D-461F-8F97-EFFDA8282C7C Q50062136-DE7BBF60-3140-4808-882F-AFF35DF4BF75 Q58603892-76F9277A-CAEC-447C-A677-568FD51272C4

P2860

Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing.

http://www.wikidata.org/entity/Q36141301

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Enhanced hepatocarcinogenesis ...... reased messenger RNA splicing.

@ast

Enhanced hepatocarcinogenesis ...... reased messenger RNA splicing.

@en

type

label

Enhanced hepatocarcinogenesis ...... reased messenger RNA splicing.

@ast

Enhanced hepatocarcinogenesis ...... reased messenger RNA splicing.

@en

prefLabel

Enhanced hepatocarcinogenesis ...... reased messenger RNA splicing.

@ast

Enhanced hepatocarcinogenesis ...... reased messenger RNA splicing.

@en

P1433

Q36141301-2A11CF10-CC1D-4FF3-81E6-3E5C6680C2FF

P1476

Q36141301-0097FE56-739E-447B-B106-E58973D1C9ED

P2093

Q36141301-28714CC0-3AAA-4B1C-B8B1-C91DE39B169A

Q36141301-48026045-AD27-4A3C-AA48-70A37812A09B

Q36141301-56555546-77BD-445A-8A7D-D33272A30438

Q36141301-95D8B2D2-16EF-4273-9EBA-7FEBEF5397B9

Q36141301-A6945FCD-2C7E-4161-92DD-BDC73DD58B5A

Q36141301-A8093DD9-D98A-4221-A246-9FCB01E790FE

Q36141301-B9F0D5D2-5D3D-4F60-B546-FBBCEBB1D2ED

Q36141301-C04E5227-2FD3-4D53-AC3A-DFC196094E26

Q36141301-C33D7487-C85A-46E5-9C90-56A5AE84B3E8

P2860

Q36141301-2FC27AFB-4627-4DCE-A9EF-5D7E888DF0DE

Q36141301-3332B340-B12E-49D6-93F3-0639771DF7BE

Q36141301-3FFCF341-5EF8-44A2-A09B-6C5F41606BA7

Q36141301-410D5F71-0C6F-4934-A201-CA3944CCEEB3

Q36141301-44BE03DB-6D36-447B-9167-F8E797DACD34

Q36141301-54601753-CCFC-4E96-B33F-464783E4FF59

Q36141301-584A5FE8-7E2A-44D1-971A-97C45FB977C9

Q36141301-683F04D5-6359-4AF1-9C78-A6DA8D41F546

Q36141301-693906ED-2DD5-4809-B5DB-A72618F76F55

Q36141301-7D84BA5D-750A-420C-A964-172B3630F9EF

P304

Q36141301-72072BB8-1EBD-4F6B-9158-5306EDE75B5E

P31

Q36141301-F2C9C977-3AFF-4D8B-A053-D0861BA47B3B

P356

Q36141301-9ABF0352-FC0D-4023-B343-ADBFF9E4F9B1

P407

Q36141301-71157E82-DA44-49ED-85EF-9562AE1E6779

P433

Q36141301-B3097BA9-3F7E-44FC-B7C8-3E22E4E0C9FA

P478

Q36141301-3D29363F-D674-4F86-821D-A60E32287629

P50

Q36141301-5748E408-8FD1-4E1B-841B-AE20515787E0

P577

Q36141301-343E04D2-3CE7-48D3-A4B2-C4097B36BEDE

P5875

Q36141301-DEBBD908-3DEB-4BBE-92E0-35C092F8113E

P698

Q36141301-B32A5409-C851-465E-814F-C73BE9AFCC93

P932

Q36141301-EF4CD8E8-F009-4540-A018-C0BFE544C2DC

P356

P1433

P1476

Enhanced hepatocarcinogenesis ...... reased messenger RNA splicing.

@en

P2093

Augusto Villanueva

http://www.w3.org/2001/XMLSchema#string

Diana Vetter

http://www.w3.org/2001/XMLSchema#string

Goutham Narla

http://www.w3.org/2001/XMLSchema#string

Michal Cohen-Naftaly

http://www.w3.org/2001/XMLSchema#string

Peri Kocabayoglu

http://www.w3.org/2001/XMLSchema#string

Rebekka Hannivoort

http://www.w3.org/2001/XMLSchema#string

Scott L Friedman

http://www.w3.org/2001/XMLSchema#string

Swan N Thung

http://www.w3.org/2001/XMLSchema#string

Youngmin A Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of human p53 activity and cell localization by alternative splicing

Gene expression profiling predicts clinical outcome of prostate cancer

KLF6, a candidate tumor suppressor gene mutated in prostate cancer

Krüppel-like transcription factors: a functional family

Molecular classification and novel targets in hepatocellular carcinoma: recent advancements

Prostate-specific Klf6 inactivation impairs anterior prostate branching morphogenesis through increased activation of the Shh pathway.

Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.

Targeted reduction of KLF6-SV1 restores chemotherapy sensitivity in resistant lung adenocarcinoma.

KLF6-SV1 is a novel antiapoptotic protein that targets the BH3-only protein NOXA for degradation and whose inhibition extends survival in an ovarian cancer model.

Nucleo-cytoplasmic localization domains regulate Krüppel-like factor 6 (KLF6) protein stability and tumor suppressor function

P304

1361-1370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.25810

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Josep M. Llovet

P577

2012-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224847084

http://www.w3.org/2001/XMLSchema#string

P698

22535637

http://www.w3.org/2001/XMLSchema#string

P932

3412196

http://www.w3.org/2001/XMLSchema#string